Advanced or Metastatic Solid Tumor Active Not Recruiting Phase 1 Trials for Pembrolizumab (DB09037)

Also known as: Advanced / Metastatic Solid Tumor / Advanced/Metastatic Solid Tumor / Advanced and Metastatic Solid Tumor / Metastatic and Advanced Solid Tumors / Advanced and/or Metastatic Solid Tumors / Advanced or Metastatic Solid Tumors / Advanced / Metastatic Solid Tumors / Advanced/ Metastatic Solid Tumors / Advanced/Metastatic Solid Tumors

IndicationStatusPhase
DBCOND0109909 (Advanced or Metastatic Solid Tumor)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05017012A Study to Evaluate the Bioavailability of Pembrolizumab (MK-3475) Via Subcutaneous (SC) Injection of MK-3475A (Pembrolizumab Formulated With MK-5180) In Advanced Solid Tumors (MK-3475A-C18)Treatment
NCT04670679A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid TumorsTreatment